| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 4798 |
| 1 | PSORIASIS | 3204 |
| 2 | DRUG INEFFECTIVE | 2544 |
| 3 | OFF LABEL USE | 2157 |
| 4 | HIDRADENITIS | 2041 |
| 5 | CONDITION AGGRAVATED | 1885 |
| 6 | PSORIATIC ARTHROPATHY | 1876 |
| 7 | INJECTION SITE PAIN | 1487 |
| 8 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 1205 |
| 9 | THERAPY INTERRUPTED | 1187 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HIDRADENITIS | 2041 | 0.2236 |
| 1 | AXIAL SPONDYLOARTHRITIS | 71 | 0.0808 |
| 2 | ORAL CANDIDIASIS | 856 | 0.0649 |
| 3 | OESOPHAGEAL CANDIDIASIS | 196 | 0.0491 |
| 4 | PSORIATIC ARTHROPATHY | 1876 | 0.0462 |
| 5 | INSURANCE ISSUE | 669 | 0.0437 |
| 6 | PRODUCT AVAILABILITY ISSUE | 881 | 0.0387 |
| 7 | CANDIDA INFECTION | 568 | 0.0336 |
| 8 | ANKYLOSING SPONDYLITIS | 419 | 0.0318 |
| 9 | PRODUCT DISTRIBUTION ISSUE | 258 | 0.0278 |